In vitro antimicrobial activity of silver-processed catheters for neurosurgery

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 2, 2009, Pages 258-265

  Bayston, Roger ^a   Vera, Litza ^a   Mills, Alison ^a,b   Ashraf, Waheed ^a   Stevenson, Oxana ^a   Howdle, Steven M ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antimicrobial catheter; External ventricular drainage; Hydrocephalus shunt; Silver impregnation

Indexed keywords

POLYURETHAN; SILICONE; SILVER;

ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL CATHETER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CATHETER; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PROPIONIBACTERIUM ACNES; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 77950198844     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp420     Document Type: Article

References (40)

1. Lozier AP, Sciacca RR, Romagnoli MF et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2002; 51: 170-81.
2. Lyke KE, Obasanjo OO, Williams MA et al. Ventriculitis complicating the use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 2001; 33: 2028-33.
3. Pfisterer W, Mühlbauer M, Czech T et al. Early diagnosis of external ventricular drainage infection: results of a prospective study. J Neurol Neurosurg Psychiatr 2003; 74: 929-32.
4. Wong GKC, Poon WS, Lyon D et al. Cefepime vs ampicillin/sulbactam and aztreonam as antibiotic prophylaxis in neurosurgical patients with external ventricular drain: results of a prospective randomized controlled clinical trial. J Clin Pharm Therapeut 2006; 31: 231-5.
5. Thompson TP, Albright AL. Propionibacterium acnes infections of cerebrospinal fluid shunts. Childs Nerv Syst 1998; 14: 378-80.
6. Bayston R, Ashraf W, Barker-Davies R et al. Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J Biomed Mater Res A 2006; 81: 705-9.
7. Ng J, Gosbell IB, Kelly JA et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006; 58: 1078-81.
8. Prabhu VC, Kaufmann HH, Voelker JL et al. Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: a review of the evidence. Surg Neurol 1999; 52: 226-37.
9. Poon WS, Ng S, Wai S et al. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomized study. Acta Neurochir 1998; 71: 146-8.
10. Bayston R, Grove N, Siegel J et al. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatr 1989; 52: 605-9.
11. Zabramski JM, Whiting D, Darouiche RO et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003; 98: 725-30.
12. Lackner P, Beer R, Broessner G et al. Efficacy of silver nanoparticles-impregnated ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008; 8: 360-5.
13. Izci Y, Secer H, Akay C et al. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res 2009; 31: 234-7.
14. Trerotola SO, Johnson MS, Shah H et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection-a randomized study. Radiology 1998; 207: 491-6.
15. Johnson JR, Kushowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 2006; 144: 116-26.
16. Saint S, Elmore JG, Sullivan SD et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998; 105: 236-41.
17. Madeo M, Davies D, Johnson G et al. The impact of using silver alloy catheters in reducing the incidence of urinary tract infection in the critical care setting. Br J Infect Control 2004; 5:21-4.
18. Rupp ME, Fitzgerald T, Marion N et al. Effect of silver-coated urinary catheters: efficacy, cost effectiveness and antimicrobial resistance. Am J Infect Control 2004; 32: 445-50.
19. Crabtree JH, Burchette RJ, Siddiqi RA et al. The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial Int 2003; 23: 368-74.
20. Samuel U, Guggenbichler J-P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 2004; 23 Suppl 1: S75-8.
21. Furno F, Morley KS, Wong B et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 2004; 54: 1019-24.
22. Galiano K, Pfeifer C, Engelhardt K et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol Res 2008; 30: 285-7.
23. Bayston R, Fisher LE, Weber K. An antimicrobial modified peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria. Biomaterials 2009; 30: 3167-73.
24. Jansen B, Rinck M, Wolbring P et al. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 1994; 9: 55-70.
25. Schoerner C, Guggenbichler J-P, Lugauer S et al. Silver catheter study: methods and results of microbiological investigations. Infection 1999; 27 Suppl 1: S54-5.
26. Bechert T, Steinrücke P, Guggenbichler J-P. A new method for screening anti-infective biomaterials. Nat Med 2000; 6: 1053-6.
27. Zhao G, Stevens SE. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals 1998; 11: 27-32.
28. Bechert T, Böswald M, Lugauer S et al. The Erlanger silver catheter: in vitro results for antimicrobial activity. Infection 1999; 27 Suppl 1: S24-9.
29. Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 2004; 53: 778-82.
30. Dowling DP, Donnelly K, McConnell ML et al. Deposition of antibacterial coatings on polymeric substrates. Thin Solid Films 2001; 398-9: 602-6.
31. Heidenau F, Mittelmeier W, Detsch R et al. A novel antibacterial titania coating: metal ion toxicity and in vitro surface colonization. J Mater Sci Mater Med 2005; 16: 883-8.
32. Lansdown ABG. Critical observations on neurotoxicity of silver. Crit Rev Toxicol 2007; 37: 237-50.
33. Greil J, Spies T, Böswald M et al. Analysis of the acute cytotoxicity of the Erlanger silver catheter. Infect 1999; 27 Suppl 1: S34-7.
34. Widmer AF, Wiestner A, Frei R et al. Killing of growing and non-growing Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35: 741-6.
35. Guevara JA, Zuccaro G, Trevisan A et al. Bacterial adhesion to cerebrospinal fluid shunts. J Neurosurg 1987: 67: 438-45.
36. Schierholz JM, Lucas LJ, Rump A et al. Efficacy of silver-coated medical devices. J Hosp Infect 1998; 40: 257-62.
37. Bayston R, Bhundia C, Ashraf W. Hydromer-coated catheters to prevent shunt infection? J Neurosurg 2005; 102 Suppl 2: 207-12.
38. Kaufmann AF, Lye T, Redekop G et al. Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 2004; 31:506-10.
39. Eymann R, Chehab S, Strowitzki M et al. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 2008; 1: 444-50.
40. Stoiser B, Kofler J, Staudinger T et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002; 50: 202-6.